Dimopoulos, M.A. Roussou, M. Gavriatopoulou, M. Psimenou, E. Eleutherakis-Papaiakovou, E. Migkou, M. Matsouka, C. Mparmparousi, D. Gika, D. Kafantari, E. Ziogas, D. Fotiou, D. Panagiotidis, I. Terpos, E. Kastritis, E., Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis, American Journal of Hematology, (91), 499-502, 2016, Wiley-Liss, Inc., 0361-8609, 1096-8652